News
-
-
-
-
-
PRESS RELEASE
EQS-Adhoc: CompuGroup Medical SE & Co. KGaA confirms discussions for potential significant investment of CVC
CompuGroup Medical SE & Co. KGaA in advanced discussions with CVC Capital Partners plc for potential investment agreement and public tender offer. Potential offer price of EUR 22.00 per share -
-
-
PRESS RELEASE
Vision Marine and Armada Partner to Produce an Innovative Electric Pontoon for North America’s Regulated Lakes
Vision Marine Technologies partners with Armada Pontoons to introduce eco-friendly electric pontoon boat designed for North America's lakes. The collaboration offers a turn-key and regulation-compliant boating solution -
PRESS RELEASE
Communiqué de presse : ASH : le rilzabrutinib a apporté un bénéfice significatif aux patients atteints de TPI dans le cadre de la première étude de phase III positive consacrée à un inhibiteur de la BTK
ASH : le rilzabrutinib montre des résultats positifs dans le traitement de la thrombocytopénie immune lors de l'étude LUNA 3. Profil d'efficacité et de sécurité prometteur -
PRESS RELEASE
Press Release: ASH: rilzabrutinib demonstrated significant patient benefit in the first positive phase 3 study of a BTK inhibitor in ITP
Positive phase 3 study shows rilzabrutinib benefits in ITP patients. Results include platelet response, reduced bleeding, improved quality of life. Safety and efficacy highlighted